Results provide evidence that jmjd-1.2 and jmjd-3.1 naturally confer protection from α-syn-induced neurotoxicity, and are used to examine the association of these gene products in DA neurodegeneration.
Abstract
Overexpression of α-synuclein (α-syn), an inherently disordered protein, triggers chronic activation of the mitochondrial unfolded protein response (UPRmt) pathway in Caenorhabditis elegans with enhanced dopaminergic (DAergic) neurodegeneration. Introduction of a loss-of-function(lf) mutation in atfs-1, the main transcriptional regulator of the UPRmt, into α-syn nematodes results in significant neuroprotection from α-syn-induced DA neuron loss. Using this sensitized neuroprotective background, we performed a F3 forward genetic screen in C. elegans atfs-1(lf) mutants to identify molecular components associated with the modulation of neurodegeneration in α-syn-expressing DA neurons. Homozygous mutant animals were examined for enhanced neurodegeneration; multiple independent alleles were uncovered. Among these, we identified new nonsense alleles encoding the histone lysine demethylases (H3K27me3), jmjd-1.2 (orthologous to human KDM7A, PHF2, and PHF8) and jmjd-3.1 (homologous to yeast CYC8). Another line carried a nonsense allele of twk-14. This gene encodes a conserved protein termed KCNK12 in mammals that facilitates passive background K+ leak currents to set and stabilize resting membrane potential. To further examine the association of these gene products in DA neurodegeneration, we used neuron-specific RNA interference, mutants, or both. DA neurodegeneration was observed in the α-syn + atfs-1(lf) background when jmjd-1.2, jmjd-3.1, or twk-14 were individually depleted. These results provide evidence that jmjd-1.2 and jmjd-3.1, which encode previously characterized H3K27me3 demethylases, and the uncharacterized twk-14 gene product, orthologous to human KCNK12, naturally confer protection from α-syn-induced neurotoxicity.
Overexpression of Kcnn1, a potassium channel subunit, appears to be neuroprotective in Parkinson’s Disease, and its action may have therapeutic implications.
Maria Nagy, W. Fenton, A. Horwich· Proceedings of the National...· 0 citations
Findings suggest that synphilin-1 promotes cell survival by suppressing p53-mediated anoikis, which could be crucial for understanding neuroprotective or pathological mechanisms in PD.
Seok Gi Kim, Ye Eun Sim, Abdurazak Aman Ketebo et al.· Bioscience Reports· 0 citations
PrPC expression levels are identified as an important modulator of nigrostriatal vulnerability and neuroinflammatory phenotype in response to αSynO, supporting the hypothesis that PrPC contributes to αSynO-mediated pathogenic mechanisms.
Flavio de Souza Júnyor, F. Leser, Sarah de Souza Albuquerque et al.· Frontiers in Neuroscience· 0 citations
In vivo evidence is provided supporting a model in which DJ-1 deficiency can promote key PD-like phenotypes in tree shrews, potentially involving PSer129αSyn accumulation, nigral dopaminergic neuron loss, and motor dysfunction.
Hao Li, Leyi Mei, Jing-Mei Cha et al.· Cell Death & Disease· 0 citations
Neuronal α-synucleinopathies, including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), lack disease-modifying therapies. We developed a Drosophila model for identifying novel glial-based therapeutic targets for α-synucleinopathies. In this model, human α-synuclein is expressed in neurons and individual g...
MJ Sodders, J. Ávila-Pacheco, EC Okorie et al.· bioRxiv· 1 citation
Data provide evidence of a specific window of time during which sustained α-synuclein burden results in direct α-synuclein-mitochondria interactions and nigral mitochondrial damage and a specific remodeling of molecular clock components occurs, providing a potential new mechanism contributing to metabolic and mitochond...
S. O’Sullivan, Adrian Kacperczyk-Perdyan, A. Ulusoy et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.